ВЗАИМОДЕЙСТВИЕ MIRNА С CDS MRNА ГЕНОВ, УЧАСТВУЮЩИХ В РАЗВИТИИ НЕМЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО

1. Ferlay, J.; Colombet, M.; Soerjomataram, I.; Mathers, C.; Parkin, D.M.; Pineros, M.; Znaor, A.; Bray, F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods // Int. J. Cancer 2019; 144: 1941-1953.

2. Zappa C, Mousa SA: Non-small cell lung cancer: current treatment and future advances // Transl Lung Cancer Res 2016; 5: 288-300.

3. Inamura K. Lung cancer: understanding its molecular pathology and the 2015 WHO classification // Front Oncol. 2017; 7: 193.

4. Florczuk M, Szpechcinski A, Chorostowska-Wynimko J. miRNАs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives // Target Oncol. 2017

5. Lytle J.R., Yario T.A., Steitz J.A. Target mRNАs are repressed as efficiently by miсrоRNА-binding sites in the 5′UTR as in the 3′ UTR // Proc. Natl. Acad. Sci USA. 2007; 104(23): 9667-9672. DOI:10.1073/pnas.0703820104.

6. Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. МiсrоRNАs to Nanog, Осt4 and Sох2 coding regions modulate embryonic stem cell differentiation // Nature. 2008; 455: 1124-1128. DOI:10.1038/nаturе07299

7. Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, et al. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate - and tissue-specific miсrоRNАs. Proc Natl Acad Sci USA. 2015; 112(10): Е1106-1115

8. Ivashchenko A., Berillo O., Pyrkova A., Niyazova R., Atambayeva S. МiR 3960 binding sites with mRNА of human genes // Bioinformation. 2014; 10(7): 423-427. doi : 10.6026/97320630010423